PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Glyceryl trinitrate - Anal fissures

PAD Profile : Glyceryl trinitrate - Anal fissures

Keywords :
GTN ointment,
Brand Names Include :
Rectogesic

Traffic Light Status

Status 1 of 2.

Status :
Green (see narrative)
Important Preferred
Formulations :
  • Ointment
Important Information :
0.4% ointment is the 1st-line treatment option in adults
Trust Alignment :
Primary Care
ASPH
RSCH
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Non Formulary
Important
Formulations :
  • Ointment
Important Information :
0.4% ointment is the 1st-line treatment option in adults. 0.1%, 0.2% and 2% ointments are non-formulary
Trust Alignment :
Primary Care
ASPH
RSCH
SASH
SABP
Links :
BNF NICE SPC
NFD1
U
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
03 April 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Glyceryl Trinitrate (GTN) 0.4% ointment is a 1st line treatment option for the treatment of anal fissure
GTN 0.4% ointment will be considered GREEN on the traffic light system for this indication

NOTE - other GTN strengths and preparations (2%, 0.2% ointment and creams) are NOT licensed and have been assigned a BLACK traffic light status - see https://surreyccg.res-systems.net/pad/Search/DrugConditionProfile/6250

Associated BNF Codes

01. Gastro-Intestinal System
01.07.04. Management of anal fissures
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More